| HTXD: Treatment: ARV Drugs |
$217,274,354 |
| HTXS: Treatment: Adult Treatment |
$176,655,054 |
| HKID: Care: Orphans and Vulnerable Children |
$89,289,531 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission |
$83,484,058 |
| HBHC: Care: Adult Care and Support |
$76,240,017 |
| HLAB: Laboratory Infrastructure |
$63,114,912 |
| HVCT: Testing: HIV Testing and Counseling |
$51,330,397 |
| HVMS: Management and Operations |
$43,152,672 |
| OHSS: Health Systems Strengthening |
$41,315,112 |
| HVOP: Sexual Prevention: Other Sexual Prevention |
$39,777,341 |
| HVSI: Strategic Information |
$34,566,539 |
| HVTB: Care: TB/HIV |
$24,361,268 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful |
$19,178,340 |
| PDTX: Treatment: Pediatric Treatment |
$15,266,846 |
| PDCS: Care: Pediatric Care and Support |
$10,117,428 |
| HMBL: Biomedical Prevention: Blood Safety |
$8,423,011 |
| HMIN: Biomedical Prevention: Injection Safety |
$4,667,191 |
